Elsevier

Brain Research

Volume 751, Issue 2, 21 March 1997, Pages 307-314
Brain Research

Research report
Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE

https://doi.org/10.1016/S0006-8993(96)01420-5Get rights and content

Abstract

Recent studies suggest that apolipoprotein E (apoE) might play a neurotrophic function in the central nervous system and that altered functioning of this molecule could result in neurodegeneration. The main objective of this study was to determine if neurodegenerative and cognitive alterations in apoE-deficient mice are reversible by infusion of recombinant apoE into the lateral ventricles. ApoE-deficient mice treated with either apoE3 or apoE4 showed a significant improvement in their learning capacity in the Morris water maze compared to saline-infused apoE-deficient mice. While this improved performance was associated with restoration of neuronal structure, the poor learning ability of apoE-deficient mice treated with saline correlated with the disrupted synapto-dendritic structure. This study supports the contention that apoE might play a neurotrophic effect in vivo and suggests that apoE might have a potential therapeutic role. © 1997 Elsevier Science B.V. All rights reserved.

Introduction

Understanding the role of apolipoprotein E (apoE) within the central nervous system (CNS) is of great importance because, as recent studies have indicated, the expression of the E4 allele of APOE is a major risk factor for the development of Alzheimer's disease (AD) [25]. ApoE is a 34 kDa protein that is primarily synthesized by astrocytes and microglial/macrophage cells in the nervous system 2, 19. During development the expression of apoE is upregulated [4]and in vitro studies have shown that apoE-containing lipoproteins can promote neuritic outgrowth in an isoform-specific fashion 9, 11, 18. In the mature central nervous system (CNS), apoE plays an important role in transporting esterified cholesterol to the neurons undergoing reinnervation where it is taken up by the low density lipoprotein (LDL) receptor-related protein (LRP) pathway and used as a precursor for the synthesis of new synaptic terminals 20, 21, 22. In fact, in apoE-deficient mice reinnervation of the perforant pathway after lesion is delayed 15, 16, 17. Furthermore, apoE might play a role during aging of the CNS in maintaining the stability of the synapto-dendritic cytoskeleton 15, 16, 17. Supporting this contention, recent studies have shown that in aged apoE-deficient mice there is synaptic and dendritic damage in the neocortex and limbic system, accompanied by disruption of the microtubular cytoskeleton 15, 16, 17. Moreover, apoE-deficient mice display significant cholinergic and memory deficits [6]. Taken together these studies suggest that apoE plays a neurotrophic/neuroprotective function within the CNS and that altered functioning of this molecule could result in neurodegeneration. In this context, the main objectives of the present study were to determine: (1) if the neurodegenerative and cognitive alterations in apoE-deficient mice are reversible by infusion of recombinant apoE into the lateral ventricles, and (2) if these in vivo effects of apoE are isoform specific.

Section snippets

Colony breeding and characterization

As previously described [17], the homozygous apoE-deficient mice were obtained by cross-breeding heterozygous mutants that were kindly provided by Dr J. Breslow (Rockefeller University, New York, NY). Additional aged homozygous apoE-deficient and wild-type mice (C57BL/6J) were provided by Drs Palinsky and Steinberg (University of California at San Diego, Department of Medicine, La Jolla, CA, USA). A total of 25 apoE-deficient homozygous mice (8 months old) and 21 wild type mice (8 months old)

ApoE-deficient mice are cognitively impaired relative to wildtype controls

During the first five days of pretraining, when the platform was visible the two groups did not significantly differ in the distance swum to reach the platform [Near Vis F(1,13)<1; Far Vis F(1,13)=3.32, n.s) (Fig. 1A). However, on the following 6 days of training when the platform was submerged (Invis), the apoE-deficient mice had a longer mean swim distance when compared to wildtype controls [F(1,13)=14.02, P<0.003] (Fig. 1A). This learning impairment was not due to motor or visual disability,

Discussion

The present study showed that infusion of apoE into the lateral ventricles of apoE-deficient mice corrects the synapto-dendritic pathology and indicates that these alterations are reversible. This in vivo neurotrophic effect is consistent with previous in vitro studies that have shown the apoE-dependent neuritic outgrowth in dorsal root ganglion neurons [9]. These effects in tissue culture were blocked by addition of anti-apoE or by reductive methylation of apoE [9]. While, in in vitro studies

Acknowledgements

This paper was supported by NIH grants AG05131, AG10689 and with funding from the Alzheimers Disease Association and Ruth K. Broad Foundation. This work was also partially supported by NIH grant RR04050.

References (29)

  • Allain, C.C., Poon, L.S., Chan, C.S.G., Richmond, W. and Fu, P.C., Enzymatic determination of total serum cholesterol,...
  • Boyles, J.K., Pitas, R.E., Wilson, E., Mahley, R.W. and Taylor, J.M., Apolipoprotein E associated with astrocytic glia...
  • Chen, K.S., Masliah, E., Mallory, M. and Gage, F.H., Synaptic loss in cognitively impaired rats is ameliorated by...
  • Elshourbagy, N.A., Liao, W.S., Mahley, R.W. and Taylor, J.M., Apolipoprotein E mRNA is abundant in the brain and...
  • Gandy, S., Stafstrom, C., Turner, B., Sweeney, D., Breslow, J., Greengard, P., Smith, J. and Ouimet, C., Aged...
  • Gordon, I., Grauer, E., Genis, I., Sehayek, E. and Michaelson, D.M., Memory deficits and cholinergic impairments in...
  • Han, S.-H., Einstein, G., Weisgraber, K.H., Strittmatter, W.J., Saunders, A.M., Vance-Pericak, M., Roses, A.D. and...
  • Han, S.-H., Hulette, C., Saunders, A.M., Einstein, G., Pericak-Vance, M., Strittmatter, W.J., Roses, A.D. and...
  • Holtzman, D.M., Pitas, R.E., Kilbridge, J., Nathan, B., Mahley, R.W., Bu, G. and Schwartz, A.L., Low density...
  • Huang, D.Y., Goedert, M., Jakes, R., Weisgraber, K.H., Garner, C.C., Saunders, A.M., Pericak-Vance, M.A., Schmechel,...
  • Ignatius, M.J., Shooter, E.M., Pitas, R.E. and Mahley, R.W., Lipoprotein uptake by neuronal growth cones in vitro,...
  • Masliah, E., Achim, C.L., Ge, N., DeTeresa, R., Terry, R.D. and Wiley, C.A., Spectrum of human immunodeficiency...
  • Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., DeTeresa, R. and Terry, R.D.,...
  • Masliah, E., Fagan, A.M., Terry, R.D., DeTeresa, R., Mallory, M. and Gage, F.H., Reactive synaptogenesis assessed by...
  • Cited by (127)

    • Influence of metformin on mitochondrial subproteome in the brain of apoE knockout mice

      2016, European Journal of Pharmacology
      Citation Excerpt :

      Indeed, Yin et al. (2014) described the elevated Aβ deposition in the aged ApoE4 mice, which was correlated inversely with hippocampal atrophy and cognitive deficits. Although apoE knockout mice are not considered as a full-blown model of Alzheimer's disease, they have been shown to exhibit mild neurodegenerative changes and behavioral abnormalities relevant to the early stages of this disorder, including synaptic and dendrite loss, increased reactive oxygen species formation and lipid peroxidation, impairments in antioxidant defense as well as in the control of the cell cycle, behavioral alterations in Morris water maze test and deficits in long-term potentiation (LTP) (Kuhla et al., 2015; Masliah et al., 1997, 1995; Shea et al., 2002; Siegel et al., 2011). Importantly, the molecular pathways governing these effect have been described as targets in pleiotropic metformin activity (Cahova et al., 2015; Chung et al., 2015; Ma et al., 2015, 2011; Singh et al., 2015).

    • Serum levels of free T3 are associated with ApoA1 and ApoA2, whereas free T4 levels are associated with ApoB and LDL-cholesterol in euthyroid cardiovascular patients

      2015, IJC Metabolic and Endocrine
      Citation Excerpt :

      ApoE participates in receptor-mediated uptake of these particles by the liver as a ligand for the low-density-lipoprotein-receptor family [21]. ApoE has a key role in neuronal maintenance and repair [22–24], and ApoE4 is a crucial risk factor for late-onset Alzheimer's disease [25]. The major site of ApoE mRNA and protein synthesis is in the liver, but the protein is also produced in the adrenals and the nervous system.

    View all citing articles on Scopus
    View full text